13C-Breath Tests in hepatology (cytosolic liver function)

European Review for Medical and Pharmacological Sciences

Volumn 8, Issue 1, 2004, Pages 47-49

  Perri, F ^a   Marras, R M L ^a   Ricciardi, R ^a   Quitadamo, M ^a   Andriulli, A ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Breath test; Cytosol; Galactose; Phenylalanine

Indexed keywords

4 ACETANISIDINE; ADENOSINE TRIPHOSPHATE; AMINOPHENAZONE; CAFFEINE; CARBON 13; CIMETIDINE; ERYTHROMYCIN; GALACTOSE; GALACTOSE 1 PHOSPHATE; PHENACETIN; PHENOBARBITAL; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PHOSPHATE; PHOSPHOTRANSFERASE; RIFAMPICIN; TYROSINE; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT;

ACCURACY; AGRANULOCYTOSIS; BREATH ANALYSIS; CATALYSIS; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG METABOLISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; GALACTOSEMIA; HEPATITIS C; HUMAN; INBORN ERROR OF METABOLISM; LIVER CIRRHOSIS; LIVER CYTOSOL; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER REGENERATION; MEASUREMENT; NON INVASIVE MEASUREMENT; PARTIAL HEPATECTOMY; PATIENT MONITORING; PHENYLKETONURIA; PHOSPHORYLATION; POSTOPERATIVE COMPLICATION; PREDICTION; REVIEW; SAFETY; SCORING SYSTEM; CYTOSOL; LIVER; METABOLISM;

BREATH TESTS; CARBON ISOTOPES; CYTOSOL; GALACTOSE; HUMANS; LIVER; LIVER FUNCTION TESTS; PHENYLALANINE;

EID: 2442701776     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Morgan MY, Milsom JP, Sherlock S. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut 1978; 19: 1068-1073.
2. 13C-tyrosine breath tests for the measurement of hepatocyte functional capacity in patients with liver cirrhosis. Chem Pharm Bull (Tokyo) 2001; 49: 1507-1511.
3. 13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg 1997; 173: 270-273.
4. 13)C] phenylalanine breath test. J Gastroenterol 2003; 38: 1086-1090.
5. Kobayashi T, Imamura H, Takayama T, et al. The role of preoperative phenylalanine breath test in hepatectomy. Hepatogastroenterology 2003; 50: 1124-1127.
6. 13C]phenylalanine breath test. Surgery 2002; 132: 849-856.
7. 13C breath test to evaluate liver functioning mass. Gut 1998; 43 (Suppl 3): S26.
8. 13C Methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Digest Liver Dis 2000; 32: 226-232.
9. 2 in healthy subjects, phenylketonuria heterozygotes and classic phenylketonurics. Clin Chim Acta 1986; 157: 253-266.
10. Perri F, Pastore M, Annese V, et al. The aminopyrine breath test. A measure of liver function and drug effects on hepatic cytochrome P-450. Ital J Gastroenterol 1994; 26: 306-317.
11. Cuatrecasas P, Segal S. Mammalian galactokinase: developmental and adaptative characteristics in the rat liver. J Biol Chem 1965; 240: 2382-2388.
12. Henderson JM, Kutner MH, Bain RP. First-order clearance of plasma galactose: the effect of liver disease. Gastroenterology 1982; 83: 1090-1096.
13. 13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther 2003; 18: 995-1002.
14. 13C-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C. Eur J Clin Invest 1999; 29: 624-629.
15. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988; 319: 1639-1650.
16. Mion F, Geloen A, Minaire Y. Effects of ethanol and diabetes on galactose oxidative metabolism and elimination in rats. Can J Physiol Pharmacol 1999; 77: 182-187.
17. Berry GT, Singh RH, Mazur AT, et al. Galactose breath testing distinguishes variant and severe galactose-1-phosphate uridyltransferase genotypes. Pediatr Res 2000; 48: 323-328.